NCT07839767
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
- Locations
-
- Queen Mary Hospital Hong Kong
Clinical trial condition
HCC - Hepatocellular Carcinoma
Explore clinical trials studying HCC - Hepatocellular Carcinoma. Study availability and eligibility vary by location and protocol.
80 public trials
38 recruiting studies
HCC - Hepatocellular Carcinoma trial results
Recruiting
Defining the Ablative Dose for Y-90 TARE
NCT07586046
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +12 more
- Locations
-
- Northwestern University Chicago, Illinois, United States
NCT07776080
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China Wuhan, Hubei, China
NCT07814014
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Mansoura University Hospitals Al Mansurah, Dakahlia Governorate, Egypt
NCT07811687
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +17 more
- Locations
-
- Clinical Medical College of Yangzhou University Yangzhou, Jiangsu, China
NCT07808164
- Conditions
- Adenocarcinoma, Breast Cancer, Breast Diseases, +55 more
- Locations
-
- Tam Anh General Hospital Hanoi, Vietnam
- Tam Anh TP. Ho Chi Minh Hospital Ho Chi Minh City, Ho Chi Minh, Vietnam
NCT06999837
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- HU Paris Nord APHP Clichy, France
- CHU de Nantes Nantes, France
NCT07801287
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Tianjin medical university institute & hospital Tianjin, China
Recruiting
A Study of Neoadjuvant Tislelizumab Plus Lenvatinib in Resectable HCC at High Risk of Recurrence
NCT07475026
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
- Locations
-
- Tianjin Medical University Cancer Institute & Hospital Tianjin, China
NCT07495735
- Conditions
- Adenocarcinoma, Atezolizumab and Bevacizumab in Hepatocellular Carcinoma, Carcinoma, +10 more
- Locations
-
- First Affiliated Hospital of Wenzhou Medical University Wenzhou, Zhejiang, China